18 June 2021

Updated ATAGI advice on the AstraZeneca vaccine

On 17 June 2021, the Australian Technical Advisory Group on Immunisation (ATAGI) reviewed their advice on the AstraZeneca COVID-19 vaccine. They recommended Pfizer as the preferred for vaccine for people aged under 60 years. This updates the previous recommendation for Pfizer over the AstraZeneca COVID-19 vaccine in those aged 16 to under 50 years.

This doesn’t change who is eligible for a COVID-19 vaccine, but it means the Pfizer vaccine is now the preferred vaccine for people under 60 years. If you have already had one dose of AstraZeneca and you did not experience severe side effects, there is no reason you cannot receive a second dose of AstraZeneca. A frequently asked questions (FAQ) document is available on the Department of Health website. This document contains FAQs about the revised ATAGI advice for people regarding COVID-19 vaccines.

Read the full disability provider alert

Visit the Department of Health website to ead the full disability provider alert